Genetic deletion of SLPI promotes inflammatory cell recruitment in a model of chronic lung disease

R. Brown (Belfast, United Kingdom), P. Ferris (Belfast, United Kingdom), C. Dougan (Belfast, United Kingdom), R. Delaney (Belfast, United Kingdom), D. Small (Belfast, United Kingdom), M. Mall (Berlin, Germany), S. Weldon (Belfast, United Kingdom), C. Taggart (Belfast, United Kingdom)

Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Session: Emerging new mechanisms of chronic lung disease
Session type: E-poster
Number: 868

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Brown (Belfast, United Kingdom), P. Ferris (Belfast, United Kingdom), C. Dougan (Belfast, United Kingdom), R. Delaney (Belfast, United Kingdom), D. Small (Belfast, United Kingdom), M. Mall (Berlin, Germany), S. Weldon (Belfast, United Kingdom), C. Taggart (Belfast, United Kingdom). Genetic deletion of SLPI promotes inflammatory cell recruitment in a model of chronic lung disease. 868

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Transcriptomic profiling of alveolar type 2 cells from mice expressing an ILD associated SFTPCI73T mutation supports their role in inflammatory cell recruitment and fibrotic lung remodeling.
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018

The role of chronic inflammation in mouse lung tumourigenesis
Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection
Year: 2005

High dimensional single cell analysis reveals unexpected immune cell types, and loss of motility and chemokine receptor expression of alveolar macrophages in chronic obstructive respiratory disease
Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Year: 2018



Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease
Source: Eur Respir J 2007; 30: Suppl. 51, 60s
Year: 2007

Impaired lung function is associated with systemic inflammation and macrophage activation
Source: Eur Respir J 2015; 45: 557-559
Year: 2015


Human rhinovirus 16 infection of human macrophages disrupts Arpin expression impairing macrophage internalization: a potential link to exacerbation in chronic obstructive pulmonary disease?
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020


Low apoptosis rate as a reason of local immune cell accumulation in interstitial lung diseases (ILD). The role of cytokine network
Source: Eur Respir J 2006; 28: Suppl. 50, 826s
Year: 2006

Increased vimentin expression in human primary bronchial epithelium reconstituted in vitro from patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013


Characterization of human airway epithelial cell lines as in vitro models of chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021

The role of the COPD susceptibility gene FAM13A in barrier function and pro-inflammatory responses of human airway epithelial cells
Source: ERS Lung Science Conference 2020
Year: 2020

Human macrophage elastase (MMP-12) expression in human emphysematous lungs: role in extracellular matrix remodelling in chronic obstructive pulmonary diseases (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 501s
Year: 2001

Nintedanib inhibits pro-fibrotic mediators from T cells with relevance to connective tissue disease-associated interstitial lung disease
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017

Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006


Characterization of the Toll-IL-1 pathway gene profile in an in-vitro model of chronic airway inflammation
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007


High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients: a reflection of an enhanced immunological function
Source: Eur Respir J 2006; 28: 113-122
Year: 2006



Human rhinovirus 16 infection of human macrophages significantly impairs their phagocytic and regulatory functions: implications in understanding chronic inflammatory lung disease
Source: International Congress 2017 – New Mechanistic Findings in COPD
Year: 2017



Role of low-grade inflammation markers and soluble cell adhesion molecules in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008


The PD-1 immune checkpoint promotes lung damage in murine models of COPD-like inflammation
Source: International Congress 2019 – Injury and repair: less is more
Year: 2019



Role of dendritic cell subsets in the early stage of cigarette smoke-induced lung inflammation
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013

B cells in different stages of development increase in the lung in a murine model of airway allergic inflammation
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009